Navigation Links
Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients
Date:3/13/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Cambridge Scientists Archive 500,000th Crystal Structure 2FDAs Woodcock Discusses Pain Management and Drug Safety in Nov 26 2009 Issue of The New England Journal of Medicine 62164 1First Time Door is Open for Family Discussion of Bipolar Disorder 62161 1First Time Door is Open for Family Discussion of Bipolar Disorder 62161 2First Time Door is Open for Family Discussion of Bipolar Disorder 62161 3American Scientific Resources Inc Opens Shanghai Location 6550 1American Scientific Resources Inc Opens Shanghai Location 6550 2